Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study - Molina, J M; Clotet, B; van Lunzen, J (Lancet HIV, 2015)
, et al; FLAMINGO study team.